hematologic cancer

Newton, Massachusetts, USA, April 21, 2026 In a major development in hematologic oncology, Karyopharm Therapeutics Inc. has announced that...

Indianapolis, Indiana | April 13, 2026 Eli Lilly and Company has announced positive topline results from the Phase 3...

TAMPA, FLORIDA, UNITED STATES — February 17, 2026 TuHURA Biosciences has filed an Investigational New Drug (IND) application with...